Dermatitis herpetiformis

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 56-59

  Kárpáti, Sarolta ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ASCORBIC ACID; AUTOANTIBODY; DAPSONE; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE; BLISTER; BONE MARROW TOXICITY; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DERMIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; GENETIC SCREENING; GLUTEN FREE DIET; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN DEPOSITION; LYMPHOMA; MALABSORPTION; ONSET AGE; PAPILLARY DERMIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; SMALL INTESTINE; SUBEPIDERMAL BLISTER; ULTRAVIOLET A RADIATION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIET, GLUTEN-FREE; HUMANS; IMMUNOGLOBULIN A; TRANSGLUTAMINASES;

EID: 83155184561     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.010     Document Type: Article

References (19)

1. Collin P., Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am J Clin Dermatol 2003, 4:13-20.
2. Kárpáti S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci 2004, 34:83-90.
3. Junkins-Hopkins J.M. Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management. J Am Acad Dermatol 2010, 63:526-528.
4. Dahlbom I., Korponay-Szabó I.R., Kovács J.B., et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010, 50:140-146.
5. Rubio-Tapia A., Murray J.A. Classification and management of refractory coeliac disease. Gut 2010, 59:547-557.
6. Neuhausen S.L., Steele L., Ryan S., et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008, 31:160-165.
7. Stamnaes J., Dorum S., Fleckenstein B., et al. Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia. Amino Acids 2010, 39:1183-1191.
8. Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996, 38:528-530.
9. Viljamaa M., Kaukinen K., Pukkala E., et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006, 38:374-380.
10. Holmes G.K., Prior P., Lane M.R., et al. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989, 30:333-338.
11. Karell K., Korponay-Szabo I., Szalai Z. J. Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs. Ann Hum Genet 2002, 66:387.
12. Dieterich W., Laag E., Bruckner-Tuderman L., et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999, 113:133-136.
13. Sárdy M., Kárpáti S., Merkl B., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002, 195:747-757.
14. Jaskowski T.D., Hamblin T., Wilson A.R. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease. J Invest Dermatol 2009, 129:2728-2730.
15. Preisz K., Sárdy M., Horváth A., et al. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 2005, 19:74-79.
16. Hall R.P., Takeuchi F., Benbenisty K.M., et al. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha. J Invest Dermatol 2006, 126:1331-1337.
17. Marietta E., Black K., Camilleri M., et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 2004, 114:1090-1097.
18. Koskinen L.L., Korponay-Szabo I.R., Viiri K., et al. Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association. J Med Genet 2008, 45:222-227.
19. Blazsek A., Sillo P., Ishii N., et al. Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid. Exp Dermatol 2008, 17:446-454.